Computational Modeling of Clinically Approved Alkylating Agents Against Epidermal and Fibroblast Growth Factor Receptors: A Step Toward Liver Cancer Therapeutics. Pjmcr 2025, 4 (4), 1970-1987. https://doi.org/10.64105/d0gq9a09.